drugset / Trial / NCT02761642
A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy and safety of subcutaneous (SC) epoetin beta in anemic participants with breast cancer undergoing chemotherapy.
Timeline
- Start
- 2004-02-29
- Primary completion
- 2007-03-31
- Completion
- 2007-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 30000 iu | Subcutaneous |